VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,000 | +133.3% | 230,742 | +1794.7% | 0.00% | +200.0% |
| Q1 2022 | $15,000 | -62.5% | 12,178 | -40.6% | 0.00% | -75.0% |
| Q4 2021 | $40,000 | -69.7% | 20,511 | -67.0% | 0.00% | -55.6% |
| Q1 2021 | $132,000 | +1100.0% | 62,124 | +291.9% | 0.01% | +800.0% |
| Q4 2019 | $11,000 | -83.1% | 15,854 | -74.1% | 0.00% | -80.0% |
| Q3 2019 | $65,000 | – | 61,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |